Ipamorelin 5mg

BPC-157 is a peptide chain derived from a naturally occurring protein in the human stomach. It is thought to interact with growth factors and cytokines, which are important signaling molecules that regulate cell growth, differentiation, and inflammation.  It has been shown to stimulate the production of extracellular matrix proteins and promote the growth of new blood vessels, both essential in tissue repair and regeneration. BPC-157 is currently being studied for its potential therapeutic effects on a variety of conditions, including gastrointestinal disorders, musculoskeletal injuries, and other inflammatory conditions.

Ipamorelin is a pentapeptide, meaning that its structure is comprised of five amino acids. It is a GH secretagogue, and is considered to be an agonist, meaning that it possesses the ability to bind certain receptors of a cell and provokes a cellular response. Ipamorelin’s operational mechanics enables the peptide to stimulate the production of pituitary gland-based expression of secretions related to growth amongst animal test subjects. At the same time, the presence of the peptide has been shown to inhibit the production of a secretion known as somatostatin. Additionally, it has been determined that Ipamorelin has the ability to boost the production of IGF-1, or Insulin-like Growth Factor 1. Its presence plays a key role in the overall growth and repair of muscular and skeletal tissue.

Thymosin Beta-4 is a 43 amino acid peptide sequence. In animal models, Thymosin Beta-4 has been shown to improve blood vessel growth, regulate wound healing, decrease inflammation, and reduce oxidative damage in the heart and central nervous system. Thymosin-beta-4 has a role in protection, tissue repair, regeneration and remodeling of injured or damaged tissues. It is also of active interest in anti-aging research. Product Contains:  TB500 5MG

Semaglutide is a derivative of the naturally occurring GLP-1, a peptide known to lower blood sugar levels and enhance insulin secretion. Research shows that Semaglutide may also improve heart, liver, and lung function while helping to slow or prevent the effects of Alzheimer’s disease. Semaglutide has been shown to significantly decrease appetite by delaying gastric emptying and reducing intestinal motility. Glucagon-Like Peptide-1 (GLP-1) Analog Shown to Stimulate Insulin and Suppress Glucagon Secretion in a Glucose-Dependent Manner.